Insiders Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 04:00:02 2024-06-06 pm EDT			5-day change	1st Jan Change
146.4 ^USD	+0.31%		+1.37%	-6.58%

01:51am	J&J-backed Rapport Therapeutics raises $136 mln in US IPO	RE
Jun. 06	Citigroup Adjusts Price Target on Johnson & Johnson to $180 From $185, Keeps Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Valneva Names New Chief Scientific Officer	May. 21	MT
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	Apr. 16	MT
Have investors resigned themselves to fewer rate cuts?	Apr. 05
Clearside Biomedical Names Victor Chong Chief Medical Officer	Mar. 18	MT
Johnson & Johnson Insider Sold Shares Worth $1,441,765, According to a Recent SEC Filing	Mar. 13	MT
LivaNova Names Vladimir Makatsaria as Chief Executive	Feb. 05	MT
Joseph Wolk, CFO of J&J: End of patent for its flagship drug	Jan. 23	MT
Top Stories at Midday: Boeing Declines After FAA Grounding; Twilio Names New CEO; Johnson & Johnson May Pay $700 Million Talc Probe Settlement; Moderna Rises on $6.7 Billion COVID-19 Vaccine Sales	Jan. 08	MT
Johnson & Johnson Names Eugene Woods as Board Member	Nov. 30	DJ
Johnson & Johnson Appoints Eugene A. Woods to its Board of Directors	Nov. 30	CI
Johnson & Johnson Announces Executive Changes	23-10-23	CI
Middle East Worries Weaken Exchange-Traded Funds, Equity Futures Premarket Tuesday	23-10-17	MT
Biomea Fusion Names Juan Pablo Frias as Chief Medical Officer, Steve Morris to Become Chief Development Officer	23-08-31	MT
US government names first 10 drugs for Medicare price negotiation	23-08-29	RE
US to name first 10 drugs for Medicare price negotiation	23-08-29	RE
Top Stories at Midday: Yellow Calls it Quits; JNJ Unit Loses Second Bid at Bankruptcy; JB Hunt Buys Nikola Trucks, Walmart Raises Flipkart Stake	23-07-31	MT
Insider Sell: Johnson & Johnson	23-07-27	MT
Insider Sell: Johnson & Johnson	23-07-27	MT
INTERVIEW - Joseph Wolk, Johnson & Johnson: inflation law may hamper innovation	23-07-20	MT
Idorsia's Commercial Chief to Step Down	23-05-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST